The Flexible Endoscopes Market presents a consistent and well-supported revenue growth trajectory, and the Flexible Endoscopes Market Size figures reflect this steady expansion, underpinned by the structural growth in gastrointestinal and respiratory disease prevalence globally, the progressive institutionalization of national colorectal cancer screening programs that create reliable and growing diagnostic procedure volumes, the continuous advancement of HD, 4K, and narrow-band imaging technologies driving premium system replacement cycles, and the accelerating transition to single-use disposable flexible endoscopes creating new recurring per-procedure revenue streams alongside capital equipment sales. Valued at US$ 6,431.04 million in 2024, the market is projected to reach US$ 9,722.55 million by 2031, recording a CAGR of 6.1% over the 2025 to 2031 forecast period.
Request Sample Pages of this Research Study @ https://www.businessmarketinsights.com/sample/BMIPUB00031681
The market's revenue foundation is built on the broad and clinically indispensable application base of flexible endoscopes across multiple high-volume diagnostic and therapeutic specialties. Gastrointestinal endoscopes generate the largest product segment revenue, anchored by the highest global endoscopic procedure volumes driven by the structural and growing incidence of colorectal cancer, gastric cancer, inflammatory bowel disease, and GERD. The premium product innovation cycle is actively advancing, demonstrated by EndoTheia Inc.'s January 2023 FDA Breakthrough Device designation for its flexible endoscopic surgery platform that radically improves minimally invasive flexible endoscopic surgical capabilities, signaling the next generation of therapeutic flexible endoscope performance and commercial potential.
The disposable flexible endoscope segment is generating growing per-procedure revenue streams alongside reusable capital equipment sales, with the July 2022 FDA 510(k) clearance of Zsquare's ENT-Flex Rhinolaryngoscope demonstrating the broadening of the single-use flexible endoscope category beyond gastrointestinal applications into ENT diagnostic procedures. Diagnostic applications lead revenue contribution, reusable endoscopes dominate usability revenues, hospitals command end-user revenues, and gastrointestinal endoscopes lead product revenues. North America generates the largest absolute regional revenue, while Asia-Pacific is forecast to deliver the highest regional CAGR through 2031 as its rising disease burden, improving healthcare infrastructure, and expanding national screening programs accelerate flexible endoscope market expansion across China, India, Japan, South Korea, and Southeast Asia.
Flexible Endoscopes Market News and Key Development:
The flexible endoscopes market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the flexible endoscopes market are:
- In July 2022, Zsquare, an Israel-based single-use endoscope manufacturer, announced that they have received Food and Drug Administration 510K clearance to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope. This Rhinolaryngoscope is a flexible, single-use endoscope indicated for use in diagnostic ENT procedures.
- In January 2023, EndoTheia Inc., a US-based medical device company, announced that it has received a Breakthrough Device designation from FDA for its EndoTheia medical device that radically improves minimally invasive flexible endoscopic surgery.
About Us
Business Market Insights is a one-stop industry research provider of actionable intelligence. Specializing in industries including Manufacturing and Construction, Semiconductor and Electronics, Healthcare, and more, the firm publishes over 500 research reports annually.
Contact Us
If you have any queries about this report or if you would like further information, please contact us: Phone: +16467917070 E-mail: sales@businessmarketinsights.com
